
Bath & Body Works, Inc. reported better-than-expected results for Q1, showing progress in its operational turnaround aimed at returning the company to growth. Despite the positive results, the company still faces challenges ahead. The stock is currently valued at about 7 times forward earnings, which appears fairly priced given the ongoing recovery. Investors should watch for further developments as the company continues its strategic overhaul.